STOCK TITAN
  1. Home
  2. Sec-filings
  3. IBIO
  4. [EFFECT] iBio, Inc. SEC Filing

[EFFECT] iBio, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 6, 2026 5:00 P.M.
Form: S-3
CIK: 0001420720
Company Name: iBio, Inc.
File Number: 333-293864

Source: View Original Filing on SEC EDGAR

Ibio

NASDAQ:IBIO

View IBIO Stock Overview →

IBIO Rankings

#5181 Ranked by Market Cap
N/A Ranked by Dividends

IBIO Latest News

Mar 9, 2026
iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss
Feb 24, 2026
iBio to Participate in Upcoming Investor Conferences
Feb 10, 2026
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
Jan 9, 2026
iBio Announces $26 Million Private Placement
Nov 24, 2025
iBio to Participate in the 8th Annual Evercore Healthcare Conference

IBIO Latest SEC Filings

Mar 9, 2026
[8-K] iBio, Inc. Reports Material Event
Mar 6, 2026
[424B5] iBio, Inc. Prospectus Supplement (Debt Securities)
Feb 27, 2026
[8-K] iBio, Inc. Reports Material Event
Feb 27, 2026
[S-3] iBio, Inc. Shelf Registration Statement
Feb 17, 2026
[SCHEDULE 13G/A] iBio, Inc. Amended Passive Investment Disclosure

IBIO Stock Data

86.36M
31.79M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK